Author Archive
Berkeley Professors newly elected to the National Academy of Sciences
The CRL would like to congratulate the five Berkeley faculty that have been newly elected to the National Academy of Sciences, one of the highest national honors that can be bestowed to a scientist. We would particularly like to congratulate our own Richard Harland
Jim Allison confronts cancer, critics with immunotherapy
The San Francisco Chronicle published a profile on Jim Allison, who performed much of his breakthrough cancer research in the Cancer Research Laboratory at UC Berkeley.
CRL Researchers show how MicroRNAs protect against tumors
Two new papers published by Cancer Research Laboratory scientists have shown how unique cellular regulators called “microRNAs” can protect against tumors. The first paper, published by the laboratory of Prof. Lin He in the journal Genes & Development, shows how a particular microRNA called miR-34 can induce the important tumor suppressor gene p53. This effect […]
Introducing iLab
We are soon transitioning the facility to a new online reservation and billing system called iLab. This new system will greatly improve the efficiency of our operations and better allow us to track instrument usage. Currently, only certain test users have been invited to use the iLab system, but we anticipate that all users will […]
Flow Cytometry Facility Is Now Open
The new Flow Cytometry Facility on the 4th floor of the Li Ka Shing building is now operational! Dr. Kartoosh Heydari is delighted to help you. This facility is equipped with a five laser Influx cell sorter (situated within a biosafety cabinet for BL2 work), and a five laser Fortessa analyzer.
Breakthrough Of The Year
The editors of Science magazine have chosen Cancer Immunotherapy as their Breakthrough of the Year for 2013. The magazine cover image features work done in the Cancer Research Laboratory at Berkeley in the 1990s by Jim Allison and colleagues. See the December 20th issue of Science for more details or read about the groundbreaking cancer […]
